Tuesday, August 22, 2017
 
 
Company News: Page (1) of 1 - 04/21/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
TraceLink Named Gold Winner of 2017 Edison Innovation Award for Data Security
 
(April 21, 2017)

NEW YORK, April 21, 2017 /PRNewswire/ -- TraceLink Inc., the World's Largest Track and Trace Network for connecting the life sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace, today announced that the TraceLink Life Sciences Cloud has been named a Gold winner of the Edison Award, awarded for innovation in the Data Security category. TraceLink was recognized at the April 20th Edison Award ceremony at The Capitale in New York City.

"Protecting and securing the integrity of the global pharmaceutical supply chain is critical to ensuring patient safety, and is the core of our company mission," said Shabbir Dahod, president and CEO, TraceLink. "We are honored to be recognized again as an Edison Award winner, a prestigious accolade that distinguishes the most innovative products on today's market. For over a decade, we have been committed to delivering an end-to-end digital supply chain solution exclusive to the life sciences industry, to enable the secure exchange of compliance information and product data between trade partners and help our customers meet global regulatory requirements."

"Our judges recognized TraceLink as a true innovator out of the many products in its category," said Frank Bonafilia, executive director of the Edison Awards.


In 2013, TraceLink was recognized as an Edison Award winner for its innovation in the health management category, joining other prior Edison winners such as Apple, GE Healthcare, SpaceX and other visionaries driving transformation in business and society.

With nearly 600 customers and more than 249,000 members on the network, the TraceLink Life Sciences Cloud is the largest globally networked track and trace pharmaceutical ecosystem that allows pharmaceutical companies, wholesale distributors, hospitals, pharmacies to exchange large volumes of data with trading partners and government entities.

The ballot of nominees for the Edison Awards was judged by a panel of more than 3,000 leading business executives including past award winners, academics and leaders in the fields of product development, design, engineering, science and medical.  

Edison Award winners represent "game changing" products and services, as well as excellence and leadership in innovation. Being recognized with an Edison Award has become one of the highest accolades a company can receive in the name of innovation and business. The awards are named after Thomas Alva Edison (1847-1931) whose inventions, new product development methods and innovative achievements literally changed the world, garnered him 1,093 U.S. patents, and made him a household name around the world. 

About TraceLink

TraceLink is the World's Largest Track and Trace Network for connecting the Life Sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace. Leading businesses trust the TraceLink Life Sciences Cloud to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. A winner of numerous industry awards including Deloitte's Technology Fast 500 (ranked number 149 in 2016), the Amazon AWS Global Start-Up Challenge Grand Prize, and the Edison Award for Innovation in Health Management, the Life Sciences Cloud is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit www.tracelink.com or follow us on LinkedIn, Twitter and Facebook.

TraceLink is funded by Goldman Sachs, FirstMark Capital, Volition Capital and F-Prime Capital.

About the Edison Awards
The Edison Awards is a program conducted by Edison Universe, a non-profit, 501(c)(3) organization dedicated to fostering future innovators. The Awards have been recognizing and honoring the best in innovations and innovators since 1987. They honor game-changing innovations that are at the forefront of new product and service development, marketing and human-centered design, and are one of the highest accolades a company can receive in the name of successful innovation. For more information about the Edison Awards complete program and a list of past winners, visit www.edisonawards.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/tracelink-named-gold-winner-of-2017-edison-innovation-award-for-data-security-300443380.html

SOURCE TraceLink

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:USA, IT (Information Technology), Security, Science, Medical, Business, Science, Other,
Related Sites: DMN Newswire ,   itbusinessnet.com ,   IBN - Security ,   HTN - Health Technology Net
Related Newsletter: DMNForums ,   Tutorial Finder ,   Review Seeker ,   IBN - IT Weekly Newsletter ,   DMN Newswire Newsletter
 
 
 
 
 
Seniors

Drugs
  • Medical Sector Contract Electronic Manufacturing Market shows lucrative growth CAGR of 8.8 % by 2022
  • Informa Names Sixth Annual SupplySide CPG Editors Choice Award Finalists
  • Growth Opportunities in the Global Sleep Apnea Devices Market 2017: Segmented by Product type, Treatment Devices, End-User and Geography - Growth, Trends, and Forecasts (2017 - 2024)
  • BIOTRONIK US Launches Smallest MR Conditional Quadripolar Cardiac Resynchronization Therapy Pacemaker
  • Global Contrast Injector Market Will Reach USD 889.3 Million by 2022: Zion Market Research

    Cancer
  • Gaucher Disease Market Is Anticipated To Witness Growth Owing To Increasing R&D Activities And Special Facility For Orphan Drugs Till 2021 | Million Insights
  • CytRx Corporation Files Preliminary Proxy Statement for Upcoming Special Meeting
  • Astronauts Showcase Space Art Created with Childhood Cancer Patients
  • Three Grant Funding Opportunities for Brain Tumor Research Funding Open Today
  • argenx to host conference call & webcast to report second quarter business update and half year 2017 financial results on August 24, 2017
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines